Enzyme inhibitors

Enzyme inhibitors are molecules that bind to enzymes and reduce their activity. Understanding how these inhibitors function is crucial for comprehending enzyme action, natural metabolic regulation, and the development of drugs and pesticides.

There are two primary types of reversible enzyme inhibitors:

• Competitive Inhibitors

  • Mechanism: Competitive inhibitor molecules possess a similar shape to the enzyme's normal substrate. They compete with the substrate molecules to bind directly to the enzyme's active site, thereby blocking the substrate from binding and preventing the reaction from taking place. No reaction occurs when the inhibitor is bound.

  • Effect on Reaction Rate: The extent of inhibition depends on the relative concentrations of the inhibitor and the substrate. If the substrate concentration is high, the substrate can out-compete the inhibitor for the active site, leading to an increase in the reaction rate (up to a point).

  • Effect on Km and Vmax: Competitive inhibitors increase the apparent Km (Michaelis–Menten constant) of the enzyme, meaning a higher substrate concentration is required to reach half of Vmax. However, they do not affect the Vmax (maximum reaction rate) because at very high substrate concentrations, the substrate can out-compete the inhibitor, allowing the enzyme to still reach its full catalytic potential. A competitive inhibitor will lower the initial rate of reaction but eventually the same amount of product will be produced as without the inhibitor.

• Non-competitive Inhibitors

  • Mechanism: Non-competitive inhibitor molecules do not have a similar shape to the substrate and do not bind to the active site. Instead, they bind to the enzyme at a different site (often referred to as an allosteric site). This binding causes a change in the enzyme's overall shape, which in turn alters the shape of the active site. As a result, the substrate can no longer fit properly into the active site, or the catalytic activity is prevented.

  • Effect on Reaction Rate: Because the inhibitor is not competing for the active site, increasing the substrate concentration will not reverse the inhibition.

  • Effect on Km and Vmax: Non-competitive inhibitors decrease the Vmax of the enzyme, as they effectively reduce the amount of functional enzyme available, but they do not affect the Km because the enzyme's affinity for the substrate is not altered, only its maximum catalytic rate. Non-competitive inhibitors lower the initial rate of reaction and the maximal rate of reaction.

• Irreversible Inhibitors (Poisons)

  • These inhibitors bind tightly and permanently to an enzyme, completely destroying its catalytic properties. Their drastic effects can occur even at low concentrations. Examples include cyanide ions, which block cytochrome oxidase in respiration, and nerve gas sarin, which blocks acetylcholinesterase in synapse transmission. Heavy metal ions like lead and mercury can also act as irreversible inhibitors by binding to -SH groups of amino acids like cysteine, affecting the enzyme's tertiary structure and active site shape.

Reversibility: Competitive and non-competitive inhibitions are generally reversible. This means the inhibitor can detach from the enzyme, allowing the enzyme to regain its full or partial activity. Irreversible inhibitors, by contrast, cause permanent inactivation.

End-Product Inhibition: A common natural control mechanism in metabolism is end-product inhibition. In this process, the final product of a metabolic pathway acts as a non-competitive, reversible inhibitor of an enzyme found earlier in the pathway (often the first enzyme). As the concentration of the end product increases, it inhibits the initial enzyme, slowing down its own production. If the end product is then used up, its concentration falls, and the enzyme becomes active again, allowing the pathway to resume. This creates a feedback mechanism that finely controls the levels of the product within narrow limits.

Graphical Representation: The effects of inhibitors can be observed when plotting the initial rate of reaction against substrate concentration. Competitive inhibitors shift the curve to the right (higher Km) but allow the reaction to reach the same Vmax, while non-competitive inhibitors lower the Vmax, resulting in a lower plateau, but do not change the Km.

Overall Significance: Inhibitors are crucial for regulating metabolic pathways within cells. They are also exploited in medicine, such as in designing drugs that target specific bacterial or viral enzymes without harming host cells (e.g., HIV reverse transcriptase inhibitors, antibiotics inhibiting bacterial cell wall synthesis or protein production), and in commercial applications like pesticides.